Harry Mansbach

Harry Mansbach

Chief Tech/Sci/R&D Officer chez 89BIO, INC.

Fortune : 2 M $ au 31/03/2024

59 ans
Health Technology
Consumer Services
Health Services

Profil

Harry H.
Mansbach
is currently the Chief Medical Officer at 89bio, Inc. He previously worked as the Director of Clinical Development & Neurosciences at GlaxoSmithKline LLC, Senior VP & Head of Global Drug Development at Bausch Health Americas, Inc., Chief Medical Officer & VP of Clinical Development at RespireRx Pharmaceuticals, Inc., Head of Global Clinical Development at Ultragenyx Pharmaceutical, Inc., and Vice President of Medical Affairs at Medivation LLC.
He was also a member of the Neurology Department at Henry Ford Health System.
Mansbach holds a doctorate from Duke University and an undergraduate degree from Yale University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
17/02/2024 158 437 ( 0,17% ) 2 M $ 31/03/2024

Postes actifs de Harry Mansbach

SociétésPosteDébut
89BIO, INC. Chief Tech/Sci/R&D Officer 01/12/2018
Tous les postes actifs de Harry Mansbach

Anciens postes connus de Harry Mansbach

SociétésPosteFin
ULTRAGENYX PHARMACEUTICAL INC. Chief Tech/Sci/R&D Officer 01/12/2018
MEDIVATION INC Chief Tech/Sci/R&D Officer 01/04/2015
RESPIRERX PHARMACEUTICALS INC. Chief Tech/Sci/R&D Officer 15/12/2006
Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
Voir l'expérience en détail de Harry Mansbach

Formation de Harry Mansbach

Duke University Doctorate Degree
Yale University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Harry Mansbach

Relations

64

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
RESPIRERX PHARMACEUTICALS INC.

Health Technology

ULTRAGENYX PHARMACEUTICAL INC.

Health Technology

89BIO, INC.

Health Technology

Entreprise privées4

Health Technology

Health Services

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Harry Mansbach